| Print
Moleculin Biotech Inc (MBRX)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
Address
2575 West Bellfort
Suite 333
Houston
TX
USA
77054
Telephone
+1 602 8899700
Forecast key dates
| Name | Key Date |
|---|---|
| Moleculin Biotech Inc Third Quarter Earnings Results for 2026 | 2026-11-13T00:00:00 |
| Moleculin Biotech Inc Annual General Meeting for 2026 | 2026-08-18T10:00:00 |
| Moleculin Biotech Inc Second Quarter Earnings Results for 2026 | 2026-08-13T00:00:00 |
| Moleculin Biotech Inc First Quarter Earnings Conference Call for 2026 | 2026-05-14T08:30:00 |
| Moleculin Biotech Inc First Quarter Earnings Results for 2026 | 2026-05-13T00:00:00 |
| Moleculin Biotech Inc Fourth Quarter Earnings Conference Call for 2025 | 2026-03-24T08:30:00 |
| Moleculin Biotech Inc Fourth Quarter Earnings Results for 2025 | 2026-03-20T00:00:00 |
| Moleculin Biotech Inc Annual Report for 2025 | 2026-03-20T00:00:00 |
| Corporate Connect Webinar Series hosted by Webull Financial | 2026-02-11T13:20:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Corporate Connect Webinar Series hosted by Webull Financial | 2026-02-11T13:20:00 |
| Live Virtual Investor Closing Bell Series | 2025-12-02T16:00:00 |
| Moleculin Biotech Inc Third Quarter Earnings Results for 2025 | 2025-11-13T00:00:00 |
| Moleculin Biotech Inc Annual General Meeting for 2025 | 2025-08-18T10:00:00 |
| Moleculin Biotech Inc Second Quarter Earnings Results for 2025 | 2025-08-13T00:00:00 |
| Moleculin Biotech Inc First Quarter Earnings Conference Call for 2025 | 2025-05-14T08:30:00 |
| Moleculin Biotech Inc First Quarter Earnings Results for 2025 | 2025-05-13T00:00:00 |
| Moleculin Biotech Inc Fourth Quarter Earnings Conference Call for 2024 | 2025-03-24T08:30:00 |
| Moleculin Biotech Inc Fourth Quarter Earnings Results for 2024 | 2025-03-21T00:00:00 |
| Moleculin Biotech Inc Annual Report for 2024 | 2025-03-21T00:00:00 |
| 37th Annual ROTH Conference | 2025-03-18T11:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.